Review: adding long-acting beta2-agonists to inhaled corticosteroids reduces asthma exacerbations more than adding antileukotrienes
- PMID: 15989308
Review: adding long-acting beta2-agonists to inhaled corticosteroids reduces asthma exacerbations more than adding antileukotrienes
Comment on
-
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. doi: 10.1002/14651858.CD003137.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. doi: 10.1002/14651858.CD003137.pub3. PMID: 15674901 Updated.